Filter Results :

Your search for antibod returned 126 reports

Sort by


United States Procalcitonin Antibody Market by Manufacturers, States, Type and Application, Forecast to 2022

19 Jun 2017  |  Published by:  Global Info Research
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved i...

$ 4,480.00

Read More

Europe Antibody Market by Manufacturers, Countries, Type and Application, Forecast to 2022

19 Jun 2017  |  Published by:  Global Info Research
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. IVD antibodies are widely used for immunology methods such as immunonephelometry and sandwich ELISA.This report only researched the antibody are for in vitro diagnostic (IVD) use.Scope of the Report...

$ 4,480.00

Read More

Antibody-Drug Conjugate (ADC) - Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
Antibody-Drug Conjugate (ADC)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Antibody-Drug Conjugate (ADC). The report provides insights on around 200+ products and 160+ different Companies, which are active in this field. The report also throws the light ...

$ 1,950.00

Read More

Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016 report provides the information across the ADCs drug value chain. The Report is focused on the marketed and pipeline scenario of the ADCs. The Report has covered the 184 A...

$ 2,950.00

Read More

Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
Summary “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication specific R&D pipelines of Bispecifc ...

$ 2,750.00

Read More

Anti GM-CSF Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti GM-CSF Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD105 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD105 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD105 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

Anti-CD152 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD152 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD152 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

Anti-CD19 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD19 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD19 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinica...

$ 1,250.00

Read More

Anti-CD22 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD22 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD22 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinica...

$ 1,250.00

Read More

Anti-CD25 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD25 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD25 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinica...

$ 1,250.00

Read More

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD274 (PD-L1) Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Disc...

$ 1,250.00

Read More

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD279 (PD-1) Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD279 (PD-1) Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discov...

$ 1,250.00

Read More

Anti-CD28 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD28 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD28 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinica...

$ 1,250.00

Read More

Anti-CD3 Antibody -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Anti-CD3 Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD3 Antibody. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

$ 1,250.00

Read More
Total 126 records.